Complementary and alternative medicine use by patients with inflammatory bowel disease: Results from a postal survey

Gastroenterologie Clinique et Biologique

Volumn 30, Issue 1, 2006, Pages 14-23

  Bensoussan, Michaël ^a   Jovenin, Nicolas ^a   Garcia, Bruno ^b   Vandromme, Luc ^b   Jolly, Damien ^a   Bouché, Olivier ^a   Thiéfin, Gérard ^a   Cadiot, Guillaume ^a  

^a SERVICE DE DERMATOLOGIE   (France)

^b Polyclinique de Courlancy   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACUPUNCTURE; ADOLESCENT; ADULT; AGED; ALTERNATIVE MEDICINE; ARTICLE; COLITIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CROHN DISEASE; DISEASE SEVERITY; DOCTOR PATIENT RELATION; ENTERITIS; FEMALE; FOLLOW UP; FREQUENCY ANALYSIS; GENDER; HEALTH SURVEY; HOMEOPATHY; HUMAN; MAGNETISM; MALE; MEDICAL INFORMATION; MEDICAL RESEARCH; MULTIVARIATE ANALYSIS; PHYSICIAN; POSTAL MAIL; PRIVATE HOSPITAL; PUBLIC HOSPITAL; QUALITY CONTROL; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SAMPLE SIZE; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; ULCERATIVE COLITIS;

EID: 32144434587     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0399-8320(06)73072-X     Document Type: Article

References (42)

1. Burgmann T, Rawsthorne P, Bernstein CN. Predictors of alternative and complementary medicine use in inflammatory bowel disease: do measures of conventional health care utilization relate to use? Am J Gastroenterol 2004;99:889-93.
2. Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL. Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med 1993;328:246-52.
3. Hilsden RJ, Verhoef MJ, Best A, Pocobelli G. Complementary and alternative medicine use by Canadian patients with inflammatory bowel disease: results from a national survey. Am J Gastroenterol 2003;98: 1563-8.
4. Moser G, Tillinger W, Sachs G, Maier-Dobersberger T, Wyatt J, Vogelsang H, et al. Relationship between the use of unconventional therapies and disease-related concerns: a study of patients with inflammatory bowel disease. J Psychosom Res 1996;40:503-9.
5. Complementary medicine is booming worldwide. BMJ 1996;313: 131-3.
6. Dilhuydy JM. L'attrait pour les médecines complémentaires et alternatives en cancérologie : une réalité que les médecins ne peuvent ni ignorer, ni réfuter. Bull Cancer 2003;90:623-8.
7. Guiraud GG. Le recours aux médecines parallèles au XXème siècle. Presse Med 2003;32:1638-41.
8. Hilsden RJ, Scott CM, Verhoef MJ. Complementary medicine use by patients with inflammatory bowel disease. Am J Gastroenterol 1998; 93:697-701.
9. Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Va Rompay M, et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 1998;280:1569-75.
10. Rawsthorne P, Shanahan F, Cronin NC, Anton PA, Lofberg R, Bohman L, et al. An international survey of the use and attitudes regarding alternative medicine by patients with inflammatory bowel disease. Am J Gastroenterol 1999;94:1298-303.
11. Trichard M, Lamure E, Chaufferin G. Study of the practice of homeopathic general practitioners in France. Homeopathy 2003;92:135-9.
12. Ernst E. The current position of complementary/alternative medicine in cancer. Eur J Cancer 2003;39:2273-7.
13. Risberg T, Kolstad A, Bremnes Y, Holte H, Wist EA, Mella O, et al. Knowledge of and attitudes toward complementary and alternative therapies; a national multicentre study of oncology professionals in Norway. Eur J Cancer 2004;40:529-35.
14. Czernichow P, Chaperon J, Le Coutour X. Problèmes communs aux enquêtes étiologiques. In: Masson, editor. Epidémiologie. Paris; 2001 p. 443.
15. Quattropani C, Ausfeld B, Straumann A, Heer P, Seibold F. Complementary alternative medicine in patients with inflammatory bowel disease: use and attitudes. Scand J Gastroenterol 2003;38:277-82.
16. Schneider B, Hanisch J, Weiser M. Complementary medicine prescription patterns in Germany. Ann Pharmacother 2004;38:502-7.
17. Moody GA, Eaden JA, Bhakta P, Sher K, Mayberry JF. The role of complementary medicine in European and Asian patients with inflammatory bowel disease. Public Health 1998;112:269-71.
18. Langmead L, Chitnis M, Rampton DS. Use of complementary therapies by patients with IBD may indicate psychosocial distress. Inflamm Bowel Dis 2002;8:174-9.
19. Hilsden RJ, Verhoef MJ. Complementary and alternative medicine: evaluating its effectiveness in inflammatory bowel disease. Inflamm Bowel Dis 1998;4:318-23.
20. Strader DB, Bacon BR, Lindsay KL, La Brecque DR, Morgan T, Wright EC, et al. Use of complementary and alternative medicine in patients with liver disease. Am J Gastroenterol 2002;97:2391-7.
21. Scott CM, Verhoef MJ, Hilsden RJ. Inflammatory bowel disease patients' decisions to use complementary therapies: links to existing models of care. Complement Ther Med 2003;11:22-7.
22. Navo MA, Phan J, Vaughan C, Palmer JL, Michaud L, Jones KL, et al. An assessment of the utilization of complementary and alternative medication in women with gynecologic or breast malignancies. J Clin Oncol 2004;22:671-7.
23. Astin JA. Why patients use alternative medicine: results of a national study. JAMA 1998;279:1548-53.
24. Verhoef MJ, Sutherland LR, Brkich L. Use of alternative medicine by patients attending a gastroenterology clinic. CMAJ 1990;142:121-5.
25. Verhoef MJ, Scott CM, Hilsden RJ. A multimethod research study on the use of complementary therapies among patients with inflammatory bowel disease. Altern Ther Health Med 1998;4:68-71.
26. Bertram PD.Melanosis coli: a consequence of "alternative therapy" for psoriasis. Am J Gastroenterol 1993;88:971.
27. Ernst E. Pour une médecine complémentaire fondée sur la preuve. Ann Med Interne (Paris) 1997;148:472-6.
28. Durazo FA, Lassman C, Han SH, Saab S, Lee NP, Kawano M, et al. Fulminant liver failure due to usnic acid for weight loss. Am J Gastroenterol 2004;99:950-2.
29. Neuman M. Effets métaboliques et interactions mé dicamenteuses provoquées par certaines substances d'origine végétale : pample-mousse, millepertuis et ail. Presse Med 2002;31:1416-22.
30. Joos S, Brinkhaus B, Maluche C, Maupai N, Kohnen R, Kraehmer N, et al. Acupuncture and moxibustion in the treatment of active Crohn's disease: a randomized controlled study. Digestion 2004;69:131-9.
31. Langmead L, Feakins RM, Goldthorpe S, Holt H, Tsironi E, De Silva A, et al. Randomized, double-blind, placebo-controlled trial of oral aloe vera gel for active ulcerative colitis. Aliment Pharmacol Ther 2004;19:739-47.
32. Ben Arye E, Goldin E, Wengrower D, Stamper A, Kohn R, Berry E. Wheat grass juice in the treatment of active distal ulcerative colitis: a randomized double-blind placebo-controlled trial. Scand J Gastroenterol 2002;37:444-9.
33. Mitsuyama K, Saiki T, Kanauchi O, Iwanaga T, Tomiyasu N, Nishiyama T, et al. Treatment of ulcerative colitis with germinated barley foodstuff feeding: a pilot study. Aliment Pharmacol Ther 1998;12:1225-30.
34. Markham AW, Wilkinson JM. Complementary and alternative medicines (CAM) in the management of asthma: an examination of the evidence. J Asthma 2004;41:131-9.
35. Ben Arye E, Ziv M, Frenkel M, Lavi I, Rosenman D. Complementary medicine and psoriasis: linking the patient's outlook with evidence-based medicine. Dermatology 2003;207:302-7.
36. Capella GL, Finzi AF. Complementary therapy for psoriasis. Dermatol Ther 2003;16:164-74.
37. Soeken KL.Selected CAM therapies for arthritis-related pain: the evidence from systematic reviews. Clin J Pain 2004;20:13-8.
38. Fisher P, Scott DL. A randomized controlled trial of homeopathy in rheumatoid arthritis. Rheumatology (Oxford) 2001;40:1052-5.
39. Smart HL, Mayberry JF, Atkinson M. Alternative medicine consultations and remedies in patients with the irritable bowel syndrome. Gut 1986;27:826-8.
40. Xiao WB, Liu YL. Rectal hypersensitivity reduced by acupoint TENS in patients with diarrhea-predominant irritable bowel syndrome: a pilot study. Dig Dis Sci 2004;49:312-9.
41. Jacoby D, St Louis T, Navarro V. Hepatitis C practice routines among Connecticut's naturopathic physicians. Am J Gastroenterol 2001;96: 2801-2.
42. Seeff LB, Lindsay KL, Bacon BR, Kresina TF, Hoofnagle JH. Complementary and alternative medicine in chronic liver disease. Hepatology 2001;34:595-603.